Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Axicabtagene Ciloleucel
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
RED
Axicabtagene ciloleucel Yescarta
®
(Infusion)
Malignant disease and immunosuppression, Other antineoplastic drugs, 08.01.05
Links found
NICE TA559: Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies (replaced by TA872 - see below)
NICE TA872: Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies
NICE TA894: Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma (not recommended)
NICE TA895: Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy